Articles tagged with Type 2 Diabetes
A comprehensive Scandinavian study has found no evidence that popular diabetes medications GLP-1 analogues increase the risk of thyroid cancer. The research analysed data from over 145,000 patients treated with these drugs and compared them to other patient groups.
A new study found that increased childhood sedentary time is associated with higher blood insulin concentration and a greater risk of excess insulin and insulin resistance. Light physical activity was shown to reduce the risk of excess insulin by 20%, while moderate-to-vigorous physical activity had a smaller effect.
Researchers found that CMS121 reduced body weight gain by 40% and improved glucose and lipid indexes in aging mice. The compound also showed anti-inflammatory effects and increased mitochondrial biogenesis, suggesting potential therapeutic applications for metabolic diseases.
A new study found that a remote team focused on education and medication management can improve guideline-directed-medical-therapy adherence in patients with type 2 diabetes. Patients who received education simultaneously with medication management demonstrated a higher rate of medication uptake.
A meta-analysis of 11 trials involving 78,607 patients found a 9% reduction in major adverse cardiovascular events (MACE) and a 14% reduction in cardiovascular death with SGLT2 inhibitors. The analysis showed consistent effects across patient groups and subgroups.
Scientists have discovered genetic variants in BSN and APBA1 genes linked to adult-onset obesity, type 2 diabetes, and fatty liver disease. These variants are associated with a significant increase in obesity risk, highlighting a new biological mechanism for the condition.
A Finnish study found that only 10% of newly diagnosed type 2 diabetics lost weight, while 3% gained weight, highlighting the challenges of achieving weight loss in these patients. The study also showed a strong association between weight gain and increased risk of microvascular and macrovascular complications.
Research suggests that for individuals under 65, maintaining a normal BMI is advisable, while those over 65 may benefit from moderate overweight. This study found a U-shaped relationship between BMI and cardiovascular death risk, with optimal BMI cut-off points varying by age group.
Studies at the University of Gothenburg found a clear shift in arterial disease risks in diabetes, with decreases in central organ diseases like heart attack and stroke, but increases in peripheral vessel complications. Closer monitoring of long-term blood sugar levels can reduce peripheral arterial disease risk by 30-50%.
A new study has found that replacing sugar with artificial and natural sweeteners in foods does not make people hungrier, but may help reduce blood sugar levels. The trial involved 53 adult men and women with overweight or obesity and found no differences in appetite or endocrine responses compared to sugar.
A comparative study of four major type 2 diabetes medications reveals differences in medication acceptance, quality of life, insulin secretion, and mortality. The GRADE Study found that younger age and higher blood sugar levels at baseline were associated with poor blood sugar control over time.
Researchers found that a high-fat diet suppresses the expression of a key protein in the gut, leading to inflammation and increased risk of Alzheimer's. Managing diabetes may be key to preventing or slowing down dementia symptoms.
A new study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes, showing significant weight loss and improved glucose control. Tirzepatide also reduces insulin dose and increases time-in-range on continuous glucose monitoring.
A new study found that women with a history of adverse pregnancy complications can reduce their risk of developing heart disease by maintaining healthy lifestyle behaviors. The research, presented at the American Heart Association's 2024 meeting, used data from the UK Biobank to evaluate the association between Life's Essential 8 score...
Researchers used the Gompertz model to predict mortality rates in people with type 2 diabetes, achieving values of over 97% accuracy in their predictions. The study found that mortality rates increase exponentially with age and are higher in females due to lower life expectancy.
Researchers at NTU Singapore have created a chip that can directly isolate blood plasma from a tube of blood in just 30 minutes, removing over 99.9% of blood cells and platelets. The device, called ExoArc, enables high-quality plasma for disease screening and research, improving diagnosis accuracy and reducing waiting times.
Research suggests that early-life tobacco exposure significantly increases the risk of developing Type 2 diabetes in adulthood, particularly for individuals with a high genetic risk. Lifestyle factors such as diet, exercise, and smoking habits may modify this risk, emphasizing the importance of healthy lifestyle choices.
Researchers found that metformin treatment does not have a positive effect on the brain development of offspring mice. The study suggests that the maternal metabolic state is crucial in determining the impact of metformin on the child's health.
Recent medications for Type 2 diabetes and weight loss have positive effects on cardiovascular and kidney health but are not always prescribed or accessible to those who need them. The studies highlight the need to address barriers to access and equity, particularly among Black adults with severe obesity.
A recent literature review discusses the underlying mechanisms of type 2 diabetes, including insulin resistance and b-cell failure. The review also explores potential therapeutic strategies, such as replenishing and regenerating b-cells, pancreas transplants, and stem cell-derived b-cells.
Researchers found that Kallistatin expression increases after weight loss, improving hepatic insulin sensitivity in obese mice. This protein may be an interesting therapeutic target for treating obesity and type 2 diabetes.
Researchers identified six novel protein biomarkers associated with incident coronary heart disease in individuals with and without type 2 diabetes. The study found that these biomarkers may offer potential new approaches to prevention and treatment of CHD.
A landmark study stratifies people with type 2 diabetes using routine variables to visualize metabolic diversity. The algorithm identifies different subtypes of the disease, which can help in targeted prevention and treatment.
Research reveals metformin treatment does not benefit offspring brain development despite positive effects on pregnant animals. Maternal metabolic state plays a crucial role in shaping the outcomes.
A Stanford Medicine study found that metformin stimulates production of lac-phe, an anti-hunger molecule abundant after exercise, leading to moderate weight loss in mice and humans. Understanding how metformin works through this pathway may lead to new strategies for lowering body mass and improving health.
Researchers have identified a gene responsible for the development of starvation-induced fatty liver in cavefish, which are able to protect their liver due to reduced fat accumulation. This genetic basis has implications for understanding and addressing liver conditions in humans, including Type 2 diabetes and obesity.
A new synthesis method for semaglutide developed by an international team of researchers may help alleviate the global shortage of the drug, which is used to treat diabetes and aid in weight loss. The method uses glycosylation, resulting in ten-fold higher yields compared to existing processes.
A new study published in the journal Stroke found that African American veterans with PTSD had a significantly higher risk of re-hospitalization after a stroke compared to those without PTSD. This was not observed among white veterans. The study highlights the importance of targeted care for high-risk populations and reducing modifiabl...
A new analysis shows that tirzepatide effectively reduces body weight across different BMI subgroups, achieving significant weight loss of 5% or more in up to 100% of participants. The treatment also demonstrated superior weight reduction compared to placebo in patients with type 2 diabetes.
New research shows tirzepatide consistently reduces bodyweight and waist circumference, with greater reductions in participants with longer disease durations. Tirzepatide also achieves higher weight loss targets and reduces waist circumference more significantly than placebo across all disease duration categories.
A recent study found that many people with type 2 diabetes know little about their condition, highlighting the need to improve communication and disease knowledge. The study revealed significant gaps in knowledge, particularly regarding blood sugar monitoring and late-stage complications like ketoacidosis.
A pilot study found that personalized dietary advice based on genetic information reduced blood glucose levels more effectively than standard coaching. The study suggests genetically-informed diets could be an effective intervention for preventing type 2 diabetes.
A recent study identified 12 genetic clusters associated with type 2 diabetes, explaining differences in clinical presentations among diverse populations. The clusters related to fat metabolism and cholesterol levels also shed light on why certain groups are more susceptible to the disease.
A study of 247,000 UK residents found a strong association between habitual short sleep duration and the development of type 2 diabetes. Even among those with healthy diets, short sleep duration was associated with an increased risk of developing the condition.
A new study from Uppsala University found that adults who sleep only three to five hours a day are at higher risk of developing type 2 diabetes. Chronic sleep deprivation cannot be compensated by healthy eating alone.
Research links low birthweight (<2.5 kg/5 lbs 8oz) to increased risk of early type 2 diabetes (59 years or younger) when combined with overweight at aged 20 years, with a 10 times greater risk compared to normal weight peers.
Researchers discovered a potential treatment for Alzheimer's disease also prevents Type 2 diabetes by blocking the formation of toxic IAPP clusters. A synthetic peptide was shown to bind and neutralize these clusters, keeping beta cells alive.
A novel AI-driven model developed by Maytal Saar-Tsechansky predicts which patients are most likely to benefit from preventive treatment for Type II diabetes. The model, trained on electronic health records of 89,191 prediabetic patients, improved both health and economic efficiency, enabling data-driven allocation of resources.
A novel study in mice with diet-induced obesity demonstrates that the knock-out of inceptor enhances glucose regulation, prompting its exploration as a drug target for type 2 diabetes treatment. Inhibiting inceptor function may enhance insulin signaling, required for beta cell function and survival.
A 12-year study found that bariatric surgery significantly improves blood glucose control and reduces the need for diabetes medications. Patients who underwent bariatric surgery experienced greater weight loss and higher rates of complete diabetes remission compared to those receiving medical therapy.
A 12-year study published in JAMA found that bariatric surgery significantly improved blood glucose control and type 2 diabetes remission compared to medical management alone. Participants who underwent bariatric surgery experienced greater weight loss, reduced medication use, and higher rates of diabetes remission.
The study found that bariatric surgery improved blood sugar control and reduced diabetes medication use more effectively than medical and lifestyle modifications. Bariatric surgery also led to superior cholesterol and triglyceride levels, which can contribute to fewer heart attacks and strokes.
After 7 to 12 years of follow-up, bariatric surgery outperformed medical/lifestyle intervention in achieving superior glycemic control with reduced medication use and higher rates of diabetes remission. Individuals who underwent bariatric surgery had better long-term management of their type 2 diabetes.
A new mouse study reveals that the gut microbiome interacts with the loss of female sex hormones to exacerbate metabolic disease. The research suggests that the gut microbiome contributes to weight gain, fat in the liver, and inflammation, particularly in women after menopause.
A new study from Edith Cowan University found that a blood test using joint cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio can predict type 2 diabetes risk more effectively. Females were most at risk with significant interaction between MHR and CRP observed.
Healthcare providers must prioritize patient experience to improve diabetes care. This includes explaining treatment options and considering each patient's level of health literacy and cultural background.
A study found that 670 nanometres of red light stimulated energy production within mitochondria, leading to increased glucose consumption and a 27.7% reduction in blood glucose levels. This non-invasive technique has the potential to impact diabetes control by reducing damaging fluctuations of blood glucose.
A study has identified 1,289 genetic markers associated with Type 2 diabetes, including 145 newly discovered markers. The research provides risk scores for diabetes complications and suggests potential genetic targets for new treatments.
Researchers from Pusan National University discovered a link between diabetes and periodontitis, showing pro-inflammatory cytokines rise in classical monocytes. The study highlights the systemic impact of these conditions on immune regulation and suggests a potential therapeutic target to reduce diabetes risk.
Researchers from Osaka University found that gargling with an antiseptic mouthwash can reduce periodontitis-related bacteria in patients with type 2 diabetes. This simple method may improve the lives of people with periodontitis-linked diseases such as diabetes, dementia, and cardiovascular disease.
A study published in the Journal of the American College of Surgeons found that gastric bypass surgery results in high rates of Type-2 diabetes remission five years after the operation, even after patients regain a significant amount of weight. In contrast, patients who underwent sleeve gastrectomy and regained their weight were five t...
A new study finds that Type 2 diabetes causes intervertebral discs to become stiffer and change shape earlier than normal. This leads to a compromised ability to withstand pressure, highlighting the need for preventative and therapeutic strategies.
A new American Heart Association scientific statement emphasizes the need for increased awareness of heart disease as a major health risk for women, particularly those with pregnancy complications. Early detection and treatment of risk factors may help prevent future heart attack, heart failure, and stroke.
Research found that boosting weekly total physical activity by just over an hour is associated with a 33% lower risk of progression to chronic kidney disease. The study also showed that longer bouts of moderate-intensity exercise, even those below 10 minutes, contribute to better outcomes.
A new study published in the American Heart Association journal Hypertension found that tirzepatide significantly lowered systolic blood pressure levels in nearly 500 adults with obesity. The results suggest treating obesity with this weight loss medication may be an effective strategy for preventing or treating high blood pressure.
Researchers found that people with Type 2 diabetes have higher levels of AGEs, leading to more viscoelastic liver tissue, which increases the risk of liver cancer. The study suggests new screening guidelines for this population, potentially improving early detection and treatment.
A recent study published in PNAS suggests that impaired macrophage function plays a key role in the development of type 2 diabetes in obese individuals. The research found that collagen breakdown is handled by macrophages, which become deactivated in obesity and insulin resistance, leading to the accumulation of collagen fragments.
Researchers at Karolinska Institutet developed a method to study liver function and disease using the cornea of mice eyes. They transplanted liver cells into the eyes, creating a non-invasive platform to monitor liver health over time.
Researchers found that SGLT2 inhibitors reduced kidney stone rates by 30% compared to GLP1 agonists and 25% compared to DPP4 inhibitors. The study included data from 716,406 adults with type 2 diabetes who took these medications.
A new study led by University of Bristol researchers found that weight loss in people with type 2 diabetes can alter levels of cancer-related chemicals circulating in the blood. Nine cancer-related proteins were changed by the weight loss intervention, suggesting a potential reduction in cancer risk.